Bessemer Group’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16K Buy
209
+68
+48% +$5.21K ﹤0.01% 1640
2025
Q1
$9K Buy
141
+16
+13% +$1.02K ﹤0.01% 1814
2024
Q4
$10K Sell
125
-628
-83% -$50.2K ﹤0.01% 1764
2024
Q3
$60K Buy
753
+201
+36% +$16K ﹤0.01% 1356
2024
Q2
$46K Buy
552
+515
+1,392% +$42.9K ﹤0.01% 1287
2024
Q1
$3K Sell
37
-9
-20% -$730 ﹤0.01% 1847
2023
Q4
$4K Sell
46
-42
-48% -$3.65K ﹤0.01% 1823
2023
Q3
$8K Buy
88
+46
+110% +$4.18K ﹤0.01% 1629
2023
Q2
$4K Buy
+42
New +$4K ﹤0.01% 1867
2023
Q1
Hold
0
2009
2022
Q4
Hold
0
2029
2020
Q3
Sell
-44,800
Closed -$4.01M 1476
2020
Q2
$4.01M Hold
44,800
0.01% 319
2020
Q1
$4.47M Buy
44,800
+1,700
+4% +$169K 0.02% 292
2019
Q4
$4.95M Buy
43,100
+300
+0.7% +$34.5K 0.02% 334
2019
Q3
$5.4M Buy
42,800
+900
+2% +$114K 0.02% 282
2019
Q2
$5.04M Buy
41,900
+7,000
+20% +$842K 0.02% 313
2019
Q1
$3.05M Buy
34,900
+1,000
+3% +$87.5K 0.01% 365
2018
Q4
$3.39M Buy
33,900
+5,700
+20% +$570K 0.01% 262
2018
Q3
$3.23M Sell
28,200
-600
-2% -$68.7K 0.01% 304
2018
Q2
$2.58M Sell
28,800
-2,500
-8% -$224K 0.01% 347
2018
Q1
$2.29M Sell
31,300
-6,700
-18% -$490K 0.01% 378
2017
Q4
$2.21M Sell
38,000
-20,700
-35% -$1.2M 0.01% 378
2017
Q3
$2.63M Buy
58,700
+700
+1% +$31.4K 0.01% 383
2017
Q2
$2.29M Buy
58,000
+400
+0.7% +$15.8K 0.01% 426
2017
Q1
$2.34M Hold
57,600
0.01% 456
2016
Q4
$2.32M Buy
57,600
+2,900
+5% +$117K 0.01% 476
2016
Q3
$1.98M Buy
+54,700
New +$1.98M 0.01% 450
2016
Q2
Sell
-46
Closed -$2K 1367
2016
Q1
$2K Buy
+46
New +$2K ﹤0.01% 1381
2014
Q3
Sell
-39
Closed -$1K 1298
2014
Q2
$1K Buy
+39
New +$1K ﹤0.01% 1351
2014
Q1
Sell
-92
Closed -$4K 1329
2013
Q4
$4K Buy
+92
New +$4K ﹤0.01% 1197